DEFA5 and colitis: The 1A8 and 4F5 clones were successfully prepared for WB, IP, and ELISA, and the results of our study show that DEFA5 as a tissue biomarker has a promising future in the diagnosis of UC, from CC or IC to authentic UC, CC, or colitis with different pathological characteristics, and lay the foundation for subsequent clinical applications.